Nuclear survivin as a biomarker for non-small-cell lung cancer

@article{Lu2004NuclearSA,
  title={Nuclear survivin as a biomarker for non-small-cell lung cancer},
  author={Bo Lu and Adriana L. Gonzalez and Pierre P. Massion and Yu Shyr and Bashar Shaktour and David Paul Carbone and Dennis E. Hallahan},
  journal={British Journal of Cancer},
  year={2004},
  volume={91},
  pages={537 - 540}
}
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC. 

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Survivin gene expression in early-stage non-small cell lung cancer.

The Journal of pathology • 2003
View 12 Excerpts
Highly Influenced

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1999
View 12 Excerpts
Highly Influenced

Survivin expression in human osteosarcoma is a marker for survival.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2003
View 2 Excerpts

Validating survivin as a cancer therapeutic target

Nature Reviews Cancer • 2003
View 1 Excerpt

Activation of cancer-specific gene expression by the survivin promoter.

Journal of the National Cancer Institute • 2002
View 1 Excerpt

Apoptosis: IAP proteins: blocking the road to death's door

Nature Reviews Molecular Cell Biology • 2002
View 1 Excerpt

Similar Papers

Loading similar papers…